201 related articles for article (PubMed ID: 8978301)
21. Deletions of the cyclin-dependent kinase inhibitor genes p16INK4A and p15INK4B in non-Hodgkin's lymphomas.
Gombart AF; Morosetti R; Miller CW; Said JW; Koeffler HP
Blood; 1995 Aug; 86(4):1534-9. PubMed ID: 7632961
[TBL] [Abstract][Full Text] [Related]
22. Proliferative fraction, bcl-1 gene translocation, and p53 mutation status as markers in mantle cell lymphoma.
Fiel-Gan MD; Almeida LM; Rose DC; Takano A; Rezuke WN; Coleman WB; Garcia NF; Tsongalis GJ
Int J Mol Med; 1999 Apr; 3(4):373-9. PubMed ID: 10085408
[TBL] [Abstract][Full Text] [Related]
23. CDK4 and MDM2 gene alterations mainly occur in highly proliferative and aggressive mantle cell lymphomas with wild-type INK4a/ARF locus.
Hernández L; Beà S; Pinyol M; Ott G; Katzenberger T; Rosenwald A; Bosch F; López-Guillermo A; Delabie J; Colomer D; Montserrat E; Campo E
Cancer Res; 2005 Mar; 65(6):2199-206. PubMed ID: 15781632
[TBL] [Abstract][Full Text] [Related]
24. Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas.
Tsuzuki T; Tsunoda S; Sakaki T; Konishi N; Hiasa Y; Nakamura M
Cancer; 1996 Jul; 78(2):287-93. PubMed ID: 8674005
[TBL] [Abstract][Full Text] [Related]
25. Cyclin D1 messenger RNA overexpression as a marker for mantle cell lymphoma.
de Boer CJ; van Krieken JH; Kluin-Nelemans HC; Kluin PM; Schuuring E
Oncogene; 1995 May; 10(9):1833-40. PubMed ID: 7753558
[TBL] [Abstract][Full Text] [Related]
26. PRAD-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma.
Bosch F; Jares P; Campo E; Lopez-Guillermo A; Piris MA; Villamor N; Tassies D; Jaffe ES; Montserrat E; Rozman C
Blood; 1994 Oct; 84(8):2726-32. PubMed ID: 7919385
[TBL] [Abstract][Full Text] [Related]
27. Molecular analysis of tumor suppressor genes, Rb, p53, p16INK4A, p15INK4B and p14ARF in natural killer cell neoplasms.
Sakajiri S; Kawamata N; Egashira M; Mori K; Oshimi K
Jpn J Cancer Res; 2001 Oct; 92(10):1048-56. PubMed ID: 11676855
[TBL] [Abstract][Full Text] [Related]
28. Expression of cell cycle regulatory genes in chronic myelogenous leukemia.
Iolascon A; Della Ragione F; Giordani L; Serra A; Saglio G; Faienza MF
Haematologica; 1998 Sep; 83(9):771-7. PubMed ID: 9825572
[TBL] [Abstract][Full Text] [Related]
29. Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma.
Chiarle R; Budel LM; Skolnik J; Frizzera G; Chilosi M; Corato A; Pizzolo G; Magidson J; Montagnoli A; Pagano M; Maes B; De Wolf-Peeters C; Inghirami G
Blood; 2000 Jan; 95(2):619-26. PubMed ID: 10627471
[TBL] [Abstract][Full Text] [Related]
30. P53, p15INK4B, p16INK4A and p57KIP2 mutations during the progression of chronic myeloid leukemia.
Güran S; Bahçe M; Beyan C; Korkmaz K; Yalçin A
Haematologia (Budap); 1998; 29(3):181-93. PubMed ID: 10069444
[TBL] [Abstract][Full Text] [Related]
31. p53 and p16INK4A mutations during the progression of glomus tumor.
Güran S; Tali ET
Pathol Oncol Res; 1999; 5(1):41-5. PubMed ID: 10079377
[TBL] [Abstract][Full Text] [Related]
32. Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells.
Drexler HG
Leukemia; 1998 Jun; 12(6):845-59. PubMed ID: 9639410
[TBL] [Abstract][Full Text] [Related]
33. p16ink4a gene and hematological malignancies.
Quesnel B; Preudhomme C; Fenaux P
Leuk Lymphoma; 1996 Jun; 22(1-2):11-24. PubMed ID: 8724524
[TBL] [Abstract][Full Text] [Related]
34. VH gene repertoire of mantle cell lymphomas.
Varade W; Marin E; Milano M; Insel R; Swerdlow S; Williams M
Ann N Y Acad Sci; 1995 Sep; 764():504-6. PubMed ID: 7486576
[No Abstract] [Full Text] [Related]
35. Translocations targeting CCND2, CCND3, and MYCN do occur in t(11;14)-negative mantle cell lymphomas.
Wlodarska I; Dierickx D; Vanhentenrijk V; Van Roosbroeck K; Pospísilová H; Minnei F; Verhoef G; Thomas J; Vandenberghe P; De Wolf-Peeters C
Blood; 2008 Jun; 111(12):5683-90. PubMed ID: 18391076
[TBL] [Abstract][Full Text] [Related]
36. PRAD1/Cyclin D1 gene overexpression in mantle cell lymphoma.
Oka K; Ohno T; Yamaguchi M; Mahmud N; Miwa H; Kita K; Shiku H; Shirakawa S
Leuk Lymphoma; 1996 Mar; 21(1-2):37-42. PubMed ID: 8907267
[TBL] [Abstract][Full Text] [Related]
37. Inactivation of both Rb and p53 pathways in mouse lung epithelial cell lines.
McDoniels-Silvers AL; Herzog CR; Tyson FL; Malkinson AM; You M
Exp Lung Res; 2001; 27(3):297-318. PubMed ID: 11293330
[TBL] [Abstract][Full Text] [Related]
38. bcl-1 rearrangement and cyclin D1 protein expression in mantle cell lymphoma.
Ott MM; Helbing A; Ott G; Bartek J; Fischer L; Dürr A; Kreipe H; Müller-Hermelink HK
J Pathol; 1996 Jul; 179(3):238-42. PubMed ID: 8774476
[TBL] [Abstract][Full Text] [Related]
39. Mantle cell lymphomas lack expression of p27Kip1, a cyclin-dependent kinase inhibitor.
Quintanilla-Martinez L; Thieblemont C; Fend F; Kumar S; Pinyol M; Campo E; Jaffe ES; Raffeld M
Am J Pathol; 1998 Jul; 153(1):175-82. PubMed ID: 9665478
[TBL] [Abstract][Full Text] [Related]
40. Effects of adenovirus-mediated expression of p27Kip1, p21Waf1 and p16INK4A in cell lines derived from t(2;5) anaplastic large cell lymphoma and Hodgkin's disease.
Turturro F; Arnold MD; Frist AY; Seth P
Leuk Lymphoma; 2002 Jun; 43(6):1323-8. PubMed ID: 12153002
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]